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Background: To improve early risk-identification in pregnancy, research on prediction models for common pregnancy
complications is ongoing. Therefore, it was the aim of this study to explore pregnant women’s perceptions, preferences
and needs regarding prediction models for first trimester screening for common pregnancy complications, such as
preeclampsia, to support future implementation.
Method: Ten focus groups (of which five with primiparous and five with multiparous women) were conducted (n = 45).
Six focus groups were conducted in urban regions and four in rural regions. All focus group discussions were audio
taped and NVIVO was used in order to facilitate the thematic analysis conducted by the researchers.
Results: Women in this study had a positive attitude towards first trimester screening for preeclampsia using prediction
models. Reassurance when determined as low-risk was a major need for using the test. Self-monitoring, early recognition
and intensive monitoring were considered benefits of using prediction models in case of a high-risk. Women
acknowledged that high-risk determination could cause (unnecessary) anxiety, but it was expected that personal and
professional interventions would level out this anxiety.
Conclusion: Women in this study had positive attitudes towards preeclampsia screening. Self-monitoring, together
with increased alertness of healthcare professionals, would enable them to take active actions to improve pregnancy
outcomes. This attitude enhances the opportunities for prevention, early recognition and treatment of preeclampsia
and probably other adverse pregnancy outcomes.
Keywords: Preeclampsia, Screening, Attitudes, Preferences, Need, Qualitative researchBackground
Preeclampsia (PE) is a pregnancy complication charac-
terised by hypertension and proteinuria, sometimes pro-
gressing in a multi-organ cluster of varying clinical
features [1]. PE complicates 2–9% of all pregnancies and
is one of the major causes of maternal and perinatal
mortality and morbidity [2].* Correspondence: N.Crombag@umcutrecht.nl
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(http://creativecommons.org/publicdomain/zeRisk identification is an essential element of antenatal
care and research on its improvement is ongoing. In
particular, a large number of first-trimester prediction
models for PE have been developed [3, 4]. Applying
these prediction models may improve risk selection by
early identification and also leaves room for preventive
measures, such as the administration of low dose aspirin
[5–7]. Prediction models can categorise women into
low- and high-risk groups and women will subsequently
receive care according to the identified risk (tailored care
pathways) [8]. Low-risk women would not need add-
itional surveillance during pregnancy, whereas high-risk
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measurements of the uterine arteries, frequent blood
pressure checks and/or urine checks for proteinuria).
The potential drawbacks and ethical concerns of the
use of such prediction models are related to the false
positive results (incorrectly categorising healthy women
as at increased risk) and false negative results (incor-
rectly categorising healthy women as at low-risk). This
may lead to unnecessary anxiety and stress, unnecessary
prenatal visits and unnecessary prophylactic medication
in women who are incorrectly categorised as high-risk
[9]. When incorrectly identified as low-risk, this may
lead to incorrect feelings of reassurance and delayed
identification when the condition occurs. However, these
drawbacks are mainly theory driven, as the true perspec-
tives, preferences and needs of pregnant women are un-
known. To meet the needs of users of care, it is necessary
to develop healthcare that reflects patients’ views and
preferences [10–12].Methods
The aim of the study was to explore pregnant women’s
perceptions, needs and preferences regarding prediction
models for preeclampsia and subsequent healthcare
pathways, to support future implementation. A focus
group approach was used to address the research ques-
tion. In focus groups data are generated by interaction
between participants representing a ‘natural-environ-
ment’. Participants present their own views but also hear
views and experiences from other participants. By
responding to each other they reveal more of their own
frame of reference [13].Recruitment of participants
As the majority of Dutch pregnant women start their
pregnancy in primary care (midwife or general practi-
tioner), the participants for this study were recruited
from 11 community midwife practices in the centre of
the Netherlands by purposive sampling. The focus
groups were conducted between April 2014–July 2015.
Potential participants had to be 18 years or older, with a
gestational age between 10 and 24 weeks, a singleton
pregnancy, and no pregnancy related complications in
their current or previous pregnancies. During recruit-
ment gestational age was maximized to 26 weeks in
order to conduct a focus group discussion with enough
participants.
Women were recruited from midwifery practices.
Women who expressed interest in participating in the
study received written information, gave schedule oppor-
tunities, provided contact details and were assigned to a
focus group based on parity, anticipating possible differ-
ences between nulliparous and multiparous women.Utilisation of prenatal screening differs between geo-
graphic regions [14–16]. Therefore, we recruited women
from high- as well as low-urbanised regions. The degree
of urbanisation was determined by the surrounding
address density of a neighbourhood, district or munici-
pality. This is a standardized method and represents the
average number of addresses per square kilometre
within a radius of one kilometre on 1 January of the year
2014 [17]. Midwifery practices located in a region with a
surrounding address density more than 2500 addresses
per km2 were determined as high urbanised, surrounding
address density less than 1000–1500 addresses per km2 as
low urbanised. First, data were collected in high urbanised
(urban) regions, next we collected data in low urbanised
(rural) regions.
Data collection
Since prediction models for preeclampsia and subsequent
healthcare pathways are not yet integrated in routine pre-
natal care in the Netherlands, measurement of percep-
tions, needs and preferences was a challenge. To provide
greater focus and specificity to the arguments for an in-
depth discussion, we decided on using a disease scenario
combined with information on current maternity care and
description of future care, presented in a video [18–20].
To ensure that medical facts were accurate, equal, rele-
vant, balanced and neutral, and to ensure that the infor-
mation was easy to understand for people who are not
experts, a group of medical experts and (pregnant) women
guided and approved the script for the video. The video
provided information on the disease scenario of PE, infor-
mation on current obstetric care, and a description of
future care. After watching the video, the participants re-
ceived a written summary of the information given in the
video. A translation of the summary given to the partici-
pants can be found in Appendix.
Before the focus group session, all participants were
asked to complete a brief questionnaire to collect infor-
mation on demographics and a personal history (age,
work experience, country of origin, parity and personal
and general experience with preeclampsia). All focus
groups were performed with a moderator guide. At each
session a moderator was present to guide the discussion
and a minutes secretary to take notes. “One researcher
(MLR) and two research-assistants (MC & JdB), with a
background in moderating focus groups, acted as mod-
erators. They were fully instructed on the research- and
interview protocol. The role of the moderator was to
guide the discussion and listen to what is said, and not
to participate, share views, engage in the discussion or
shape the outcome of the group interview. The moder-
ator summarised the discussion and after each session
debriefs with the minutes secretary. The sessions were
audio and video-taped and viewed after each session by
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the focus group interviews (NC) [21]. The focus group
sessions were conducted using a semi-structured inter-
view protocol which comprised the following topics:
participants’ knowledge of the target condition (i.e. PE);
participants experience and perception towards PE;
preferences and need regarding utilisation of prediction
models for PE; advantages and disadvantages of predic-
tion models for PE; level and amount of pre- and post-
test counselling and information. Focus group sessions
lasted approximately 90 minutes, were digitally recorded
(audio and video) and transcribed verbatim. After six
focus groups in urban regions and four in rural regions,
no new information was collected anymore and it was
agreed that saturation was reached and recruitment was
stopped. Thus, we performed 10 focus groups compris-
ing a total of 45 pregnant participants.
Data analysis
Data analysis was performed on basic content, to
describe and categorize arguments and to identify links
between women’s characteristics and arguments. The
transcripts were coded systematically to identify patterns
and major themes in the focus group transcripts. To
capture the group dynamics and interactions between in-
dividual participants we have used whole group analysis as
described by Spencer et al. [22]. Data produced by the
group are used as a whole without specifying individual
contributions. The group will then become the unit of
analysis and will be treated as unit of individual data.
The focus group transcripts were systematically coded
(thematic analysis) by using the computer software
Nvivo10. First, we conducted open coding, in which we
assigned initial codes to text fragments. Two researchers
(NC and DM or TK) independently conducted analysis
of the transcript to reach an understanding on theFig. 1 Categories and subcategories of coded themes used in this studyassigned open codes (subcategories). Next, the initial
codes were combined by making connections between
categories and placing them in a broader context related
to the research subject [23]. This resulted in three
described and arranged categories: perceptions, needs,
and preferences. For example, the coding themes
‘reassurance’, ‘professional monitoring’, ‘self-monitoring’
and ‘increased knowledge’ all became subcategories of
‘need (for testing)’ (Fig. 1).
Results
In general, the focus groups were lively and participants
were motivated to participate. The women participating in
the focus groups were able to formulate arguments and the
group interaction contributed to deepen the discussions.
Baseline characteristics
A total of 10 focus groups were conducted (n = 45). Six
focus groups with women residing in highly urbanised
regions (n = 27), four focus groups with women residing
in low urbanised regions (n = 18). Within the two regions,
half of the groups consisted of primiparous women, half
multiparous women. The majority of participants were
highly educated, had a paid job and were Dutch. In high-
urbanised regions the mean age was 33.7 and in rural
regions mean age was 29.6. Participant characteristics are
summarized in Table 1.
Perception
Most women had some knowledge of PE, mainly based
on experiences from friends, family or colleagues. These
women considered PE a serious complication for both the
mother and child (perception). All women in this study,
except for one who initially had some reservations, had
positive attitudes towards prediction models for PE. When
available, all women would eventually participate.
Table 1 Socio-demographic characteristics of the study
population in high urbanisation and low urbanisation regions
High urbanisation
(n = 27)
Low urbanisation
(n = 18)
Nulliparous
(n = 11)
Multiparous
(n = 16)
Nulliparous
(n = 8)
Multiparous
(n = 10)
Mean maternal age 33.8 33.7 28.3 30.5
Marital status
Partner 11 16 8 10
Single – – – –
Highest educationa
Low – – 1 –
Intermediate 1 3 3 4
High 10 13 4 6
Occupation
Paid job 11 16 7 9
Unemployed – – 1 –
Housewife – – – 1
Etnic originb
Dutch 9 14 8 10
Non-Dutch 2 2 – –
General experience
with preeclampsiac
Yes 4 13 5 5
No 7 3 3 5
aEducation was defined as ‘low’ (elementary school, lower level of secondary
school), ‘Intermediate’ (higher level of secondary school and intermediate
vocational training) and ‘high’ (higher vocational training and university)
bEthnic origin in the Netherlands is defined by country of birth of a person’s
parents. If one or both parents are born outside the Netherlands a person is
considered non-Dutch (Dutch National Office of Statistics; Statistics of the
Netherlands)
cGeneral experience was described as ‘have or have not people in your social
environment who have experienced preeclampsia’
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Arguments shared in the focus groups were mainly in
favour of prediction models for PE. In general, women
preferred to receive more information on possible com-
plications in pregnancy. Some multiparous women even
regretted not being informed about possible complica-
tions in an earlier pregnancy to create more alertness
(increased knowledge).
‘It worries me that I have not been informed on this
(preeclampsia) in my former pregnancy or in this
pregnancy […], it is quite a serious condition, and
I would have appreciated to receive a list with
symptoms to be aware of, just suppose I would have
had these symptoms and would not have recognised it.
So I am actually more worried about the lack of
information’ [F16, multiparous, highly urbanised
region].Testing was considered as an additional tool for
increased monitoring of their pregnancy, both by
themselves and their healthcare providers/midwives.
Knowledge on their personal (high) risk was perceived
beneficial as this would enable them to pay more
specific attention to signals potentially related to PE
(defined as self-monitoring), while they also expected
their healthcare professionals to be more alert on spe-
cific symptoms. As a result they expected improve-
ment in early recognition of complications and timely
consultation of a healthcare provider. Knowledge on
their personal (high) risk would also enable women to
take preventive actions if possible (professional- and
self-monitoring).
‘If you would receive information like “be aware of
headache and blurred vision” and the information like
how it was presented in the information video, that
will possibly increase your alertness’ [P6, primiparous,
low urbanised region].
‘And suppose PE screening will be implemented, they
(healthcare professionals) will be aware of your high-
risk, and consequently be more alert, when compared
to being at low-risk’ [M9, multiparous, low urbanised
region].
Anxiety and reassurance played a major role in the
need to be screened. Being categorised as low-risk
was considered reassuring and was for some women
the main reason they would opt for screening,
although they acknowledged that the result was a risk
estimation only (reassurance). At the same time, it
was acknowledged that a high-risk result could cause
increased anxiety, but possibilities of self-monitoring,
preventive means and more intensive professional
monitoring could possibly level out these feelings of
anxiety (anxiety).
‘….also because there will be more consultations, there
will be more often a moment of reassurance. And if
the healthcare professional pays close attention to my
condition, this will possibly compensate my feelings of
anxiety due to a high-risk” [F4, primiparous, highly
urbanised region].
Few women had doubts regarding participation in
screening for PE. These women felt that screening
may cause unnecessary anxiety and unnecessary
medicalisation of pregnancy. They expected that prior
to severe pregnancy complications, they would
experience alarming physical complaints, so feeling in
good shape was reassuring enough (medicalisation).
Ta
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unnecessary anxiety, as women will be worried
and think: “O no, I have a high-risk, so I will get
this disease” [F22, multiparous, highly urbanised
region].
‘..I find it important to be screened, but you also have
to take things as they come. It is your body doing the
work and you have to trust on the signals of your body’
[M1, multiparous, low urbanised region].Preferences
The participants in this study gave clear views on
preferences they had regarding a hypothetical test-
offer. Quotes related to test preferences are given in
Table 2. Prior to screening they would like to be in-
formed on the screening method in general. They also
wished to be informed about the condition and how
screening results would be beneficial. Moreover,
women would like information on the consequences
and follow-up in case of a high-risk. Information
should be provided by their midwife at the first con-
sultation. Leaflets, specific websites or information
meetings prior to screening were appreciated to sup-
port oral information. Results should be communi-
cated in person, preferably with an option to discuss
a screen positive result. Women agreed that post-
counselling information, in case of a high-risk, wasble 2 Study participants test-preferences regarding the hypotheti
ormation provision ‘I would like to know these perce
not enough, I want complete inf
my chances of developing the co
chances of developing the condi
I know all these things, what are
‘Some oral information, but also
are back home’. [P8, primiparous
dication ‘I am positive towards early iden
throughout my pregnancy. Calci
[P8, primiparous, low urbanised
‘I found it a bit strange, I have n
any pain, it is better not to take
urbanised region].
oice I think that everybody should ma
[P7, primiparous, low urbanised
‘I would like to hear this (screenin
do all these exams....I don’t mind
[F1, primiparous, highly urbanise
‘Regarding use of aspirin and ca
information about these medicin
urbanised region].
se-positive classification ‘I fully agree…for me it would be
20% chance of developing the d
certainly participate. I don’t think
urbanised region].essential. Information provision in case of low-risk
results should be focused on symptoms to create
general awareness (Information provision).
Opinions were divided regarding the use of pre-
ventive medication. In particular, women did not like
the idea of using medication in case of a false positive
screening result. Calcium supplements were considered
less problematic as calcium was considered as a natural
substance, whereas aspirin was perceived as a drug. Expli-
cit information on the effects of medication, long-term
side effects and proven effectiveness were considered
crucial for the use of preventive medication (Medication).
After receiving information prior to screening
(counselling) most women preferred to have a choice
whether or not to be screened, although for some
women this pre-test counselling was not necessary.
The majority of women also wanted to have a choice
whether or not to take preventive medication. Some
also preferred to have a choice in who would be re-
sponsible for the follow-up after a high-risk result
(Choice).
The possibility of receiving a false positive result
was not perceived as something negative. Women
found it reassuring to know that in case of deter-
mined high-risk, the chances of developing the con-
dition are small. Besides, a high-risk would give
them direct access to specialised care, which was a
reassuring thought for most women (False positive
results).cal offer of prediction models for preeclampsia
ntages, only information ‘you are categorised as high or low-risk’ for me is
ormation. For example what does it mean to be at low-risk, and what are
ndition. And what does it mean to be at high-risk and what are my
tion then. What are options for prevention and treatment. And when
my options? [F9, primiparous, highly urbanised region].
some written information, so you can look the information up when you
, low urbanised region]
tification of your risk, but I feel some reluctance for taking aspirin
um, for me is OK, you can find this in pregnancy vitamins as well’
region].
o medical background, but I have been told that in case of a headache or
aspirin as a painkiller, but paracetamol instead’ [F15 multiparous, highly
ke their own choices (to participate or not). That is my opinion
region].
g for PE) afterwards. They will take a blood test anyway, and then they will
. And if they inform me about this afterwards, that is early enough’
d region].
lcium, for me this should be a choice. First I would like to receive extensive
es [….] and than discuss what are the options [F4 primiparous, highly
really reassuring, because if you are determined as high-risk, there is only a
isease. Well, if I would have a chance of 80% to win the lottery, I would
it (high-risk identification) would worry me’ [F13, multiparous, highly
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Multiparous women more often referred to earlier
experiences, which mostly provided them with more
confidence and knowledge. Therefore, for some, referral to
specialised care in case of high-risk was not essential. They
suggested a combined pathway (midwife/obstetrician) or
intensive pathway with a midwife only (primary care).
‘A gynaecologist is in a hospital, with different smell,
different light....A midwife more often is close to your
house, whereas a gynaecologist is not. A midwife is
easy accessible, but if you have a high-risk.....well, I
don’t think it is necessary to be with a gynaecologist
for the rest of your pregnancy’ [M3, multiparous, low
urbanised region].
Nulliparous women needed more support and con-
firmation of their wellbeing. In this group there was a
more positive attitude towards specialised care, in which
they expected to receive more intensive monitoring,
which would give them more reassurance (specialised
care).
‘I would prefer to have direct access to specialised care
in case of any alarming symptoms or feelings of
discomfort, instead of convincing someone that they
have to take my complaints in serious consideration.
So yes, from that point of view, being at high-risk
provides me with this direct access’ [F5, primiparous,
highly urbanised region].
Women in highly urbanised regions more often felt
the need to receive as much information as possible
and intensive monitoring of their pregnancy. They
more often felt that specialised care was more re-
assuring and did not mind to go to the hospital to
receive care. Women from low-urbanised regions also
felt the need to receive information, but more often
preferred care close to their homes (mostly being
midwifery care). Besides, they appreciated the per-
sonal care and easy access and felt confident that
their midwife was well equipped to monitor their
health. They more often referred to ‘trust in their
own bodies’ and ‘not to create problems if not
present’.
Discussion
Main findings
The purpose of this study was to explore perceptions,
needs and preferences of pregnant women regarding
prediction models for preeclampsia and subsequent
care. The results of our study suggest that the major-
ity of women in this study had a positive attitude
towards preeclampsia screening and were willing toparticipate when available, which is in line with
earlier research regarding PE screening [24, 25].
When identified as high-risk, self-monitoring, together
with increased alertness of healthcare professionals,
was perceived as a means to take active actions to
potentially improve pregnancy outcomes. Whether
self-monitoring is an effective screening instrument
for PE is not clear and should be further studied, but
for our study participants it was experienced as some-
thing positive as they felt they could play a role in
early detection or even play an active role in care for
their pregnancy themselves.
In the Netherlands pregnant women are initially
considered as low-risk, and the majority start their
pregnancy in primary care [26], characterised by its low-
medicalised approach and prevention of unnecessary
concerns and anxiety [27]. Anxiety in the perinatal
period is common among pregnant women and
increases throughout pregnancy [28, 29]. Participants
in our study also anticipated the possibility of ele-
vated feelings of anxiety. But by active engagement
and alertness in their personal health, they expected
the disadvantage of anxiety to be levelled out. Which is
in line with findings of Simeone et al. [25], who demon-
strated that participating in a first-trimester preventive
program for PE did not increase levels of anxiety [25].
In this study the majority of women had no problem
with specialised care in case they should be classified as
high-risk, while some even preferred specialised care in
general. This is an interesting finding, as the Dutch
obstetric system in which these women received care is
midwifery-led and characterised by its low-medicalised
approach and high satisfaction rates are suggested with
this type of care [30–32].
Preference for specialised care was more (but not
solely) present in women living in the urban region
and in nulliparous women. A possible explanation for
this is that for women residing in a city, accessibility
to a hospital or midwifery practice is equal, whereas
for women in rural areas this is not. Nulliparous
women lack the experience of a prior pregnancy and
might experience more feelings of uncertainty.
Increased interventions and monitoring possibly gives
them a feeling of control over the situation and
therefore more reassurance.
Strengths and limitations
This study highlights the preferences, perceptions and
needs of the care-users, and provides important informa-
tion to understand women’s perspective. Incorporating
the patient perspective is important for the development
of patient centred care.
The results of this study were mainly in favour of screen-
ing for maternal complications, but some weaknesses of
Advantages Disadvantages
• Pregnant women will only be
classified as ‘ill’ if the condition
(preeclampsia) is indeed diagnosed
• The onset of preeclampsia can
be suddenly and severe, the
condition can only be
diagnosed when the pregnant
women is already (severly) ill
• No unnecessary concern will
be raised in the beginning
of pregnancy
• Only women who had a
previous preeclampsia will
receive intensive monitoring
during pregnancy
• No medical interventions unless
the condition is diagnosed
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pants were low and most were highly educated and
were Dutch. The participants’ characteristics, such as
educational level, may have biased our results. There-
fore future research should focus on generalisation of
our findings and should be tested in large representa-
tive groups of women. Furthermore, one multiparous
woman was erroneously allocated to a focus group of
nulliparous women and may have influenced the nul-
liparous women’s opinions. One group of multiparous
women included a woman that had had PE in a
former pregnancy and that may have influenced the
other participants. Nevertheless, the findings in both
groups were not substantially different from the other
groups.
Interpretation
In general, people have a preference to have influence
on events in their life [33]. By knowing a possible
high-risk, women may feel they can take action to
improve their outcomes. This is in line with earlier
findings regarding women provided with risk informa-
tion for preeclampsia. These women were very recep-
tive to more intensive monitoring and engaged in
efforts to reduce their risk of preeclampsia, a
phenomenon also known as the illusion of control
[24]. Certain activities, such as active involvement,
gives people the feeling that they have more control
over a situation [34]. So, if a test provides informa-
tion on someone’s (near) future, if they have the feel-
ing they can improve the situation, people are more
willing to take a test, which is in line with findings
regarding genetic testing [35].
The findings of our study potentially open up possi-
bilities for the use of PE screening in current obstet-
ric care [24]. There is some evidence on preventive
effects of low-dose aspirin and calcium [36] and early
risk identification can support healthcare professionals
and prospective mothers in early recognition of the
onset of the disease. This might be an important im-
provement, as severe complications in PE are related
to substandard care and relatively late identification
of the disease [37, 38]. Perhaps the most important
potential benefit of PE screening is increased cost-
effectiveness. It allows intensified surveillance in
women identified as at high-risk and avoidance of too
many antenatal visits, diagnostic and therapeutic
interventions in those identified as at low-risk.
On the contrary, as there is still no real cure for
PE, we should also be aware of not giving women the
illusion of reassurance by the increase of medical in-
terventions. Therefore, implementation of PE testing
can be of added value, but should be carefully imple-
mented. The results of our study provided us withsome meaningful suggestions from the study partici-
pants regarding future implementation of the test.
Obviously, they were related to the personal needs of
these participants, but they also reflected on possible
drawbacks. As a result, we suggest that prediction models
for PE should be offered with clear and realistic oral pre-
test information in which the pregnant woman is a part-
ner on equal term. Unsolicited support when at high-risk
to reduce stress and support coping [39] was among the
suggestions. The use of medication should be well sup-
ported in terms of safety, reliability, usefulness and long-
term effects.
The positive attitude towards PE screening as found in
this study differs greatly from that on Down syndrome
screening in the Netherlands. The latter only has an up-
take of 27% [40]. In the present focus groups we did not
address this issue, but differences in attitude may relate
to ethical considerations related to the treatment options
and feelings of anxiety [14, 41]. Early studies suggest that
anxiety levels are more elevated following a screening
test that has impact on foetal health, than following one
that has impact on maternal health [42]. Being able to
observe one selves more intense, apply preventive means
and receive more intense care are seen as relevant inter-
ventions to be prepared or even improve pregnancy
outcomes.
Conclusion
In conclusion, women in this study had positive atti-
tudes towards PE screening. Identification of women
at high-risk offers opportunities for prevention, early
recognition and treatment. Because of the lack of
proven effective prevention of PE and the possibility
of misclassification pre and post test counselling re-
mains essential.
Appendix
Translation of summary provided to the focus group
participants.
Advantages versus disadvantages of current risk strati-
fication strategy in the Netherlands.
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 Prenatal visits in primary care (midwife).
 Similar to current prenatal care.
High risk care pathway – guided by prediction model.
 Prenatal visits in secondary care.
 Supplementation of low-dose aspirin and calcium.
 Doppler measurement of the uterine arteries at
20 weeks anatomy scan.
 Follow-up of fetal growth by ultrasound (not
routinely performed in the Netherlands).
 Check for proteinuria.
Advantages versus disadvantages of proposed risk
stratification strategy in the Netherlands.Advantages Disadvantages
• Pregnant women who are
considered low-risk truly
have a low risk of developing
preeclampsia
• 80% of women who are
considered high-risk will receive
intensive care while they would
never have developed
preeclampsia
• Pregnant women who are
considered high-risk can lower
this risk by supplementation of
low-dose aspirin and calcium
• These women may experience
unnecessary anxiety
• Using prediction models for
preeclampsia allows for
personalized tailored care
• 1% of women considered low-risk
will still develop preeclampsiaAbbreviation
PE: Preeclamsia
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